Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies - PubMed (original) (raw)
Review
Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies
Keith T Wilson et al. Gastroenterology. 2007 Jul.
Abstract
Helicobacter pylori infects the stomach of half of the human population worldwide and causes chronic active gastritis, which can lead to peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. The host immune response to the infection is ineffective, because the bacterium persists and the inflammation continues for decades. Bacterial activation of epithelial cells, dendritic cells, monocytes, macrophages, and neutrophils leads to a T helper cell 1 type of adaptive response, but this remains inadequate. The host inflammatory response has a key functional role in disrupting acid homeostasis, which impacts directly on the colonization patterns of H pylori and thus the extent of gastritis. Many potential mechanisms for the failure of the host response have been postulated, and these include apoptosis of epithelial cells and macrophages, inadequate effector functions of macrophages and dendritic cells, VacA inhibition of T-cell function, and suppressive effects of regulatory T cells. Because of the extent of the disease burden, many strategies for prophylactic or therapeutic vaccines have been investigated. The goal of enhancing the host's ability to generate protective immunity has met with some success in animal models, but the efficacy of potential vaccines in humans remains to be demonstrated. Aspects of H pylori immunopathogenesis are reviewed and perspectives on the failure of the host immune response are discussed. Understanding the mechanisms of immune evasion could lead to new opportunities for enhancing eradication and prevention of infection and associated disease.
Similar articles
- Inflammation, immunity and vaccines for Helicobacter pylori.
Del Giudice G, Michetti P. Del Giudice G, et al. Helicobacter. 2004;9 Suppl 1:23-8. doi: 10.1111/j.1083-4389.2004.00245.x. Helicobacter. 2004. PMID: 15347302 Review. - Helicobacter pylori immunology and vaccines.
Vorobjova T, Watanabe T, Chiba T. Vorobjova T, et al. Helicobacter. 2008 Oct;13 Suppl 1:18-22. doi: 10.1111/j.1523-5378.2008.00636.x. Helicobacter. 2008. PMID: 18783517 Review. - Towards the development of vaccines against Helicobacter pylori: status and issues.
Del Giudice G. Del Giudice G. Curr Opin Investig Drugs. 2001 Jan;2(1):40-4. Curr Opin Investig Drugs. 2001. PMID: 11527009 Review. - Helicobacter pylori and its effect on innate and adaptive immunity: new insights and vaccination strategies.
Sundquist M, Quiding-Järbrink M. Sundquist M, et al. Expert Rev Gastroenterol Hepatol. 2010 Dec;4(6):733-44. doi: 10.1586/egh.10.71. Expert Rev Gastroenterol Hepatol. 2010. PMID: 21108593 Review. - Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C, Roussel Y, Harris AG, Wren BW, Morrow JW, Bajaj-Elliott M. Hatzifoti C, et al. Helicobacter. 2006 Apr;11(2):113-22. doi: 10.1111/j.1523-5378.2006.00385.x. Helicobacter. 2006. PMID: 16579841
Cited by
- The interleukin-17 receptor B subunit is essential for the Th2 response to Helicobacter pylori, but not for control of bacterial burden.
Horvath DJ Jr, Radin JN, Cho SH, Washington MK, Algood HM. Horvath DJ Jr, et al. PLoS One. 2013;8(3):e60363. doi: 10.1371/journal.pone.0060363. Epub 2013 Mar 22. PLoS One. 2013. PMID: 23533678 Free PMC article. - Dynamics of Oxidative Stress in _Helicobacter pylori_-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer.
Tsukanov VV, Smirnova OV, Kasparov EV, Sinyakov AA, Vasyutin AV, Tonkikh JL, Cherepnin MA. Tsukanov VV, et al. Diagnostics (Basel). 2022 May 11;12(5):1203. doi: 10.3390/diagnostics12051203. Diagnostics (Basel). 2022. PMID: 35626358 Free PMC article. - Stimulation of dendritic cells with Helicobacter pylori vacuolating cytotoxin negatively regulates their maturation via the restoration of E2F1.
Kim JM, Kim JS, Yoo DY, Ko SH, Kim N, Kim H, Kim YJ. Kim JM, et al. Clin Exp Immunol. 2011 Oct;166(1):34-45. doi: 10.1111/j.1365-2249.2011.04447.x. Clin Exp Immunol. 2011. PMID: 21910723 Free PMC article. - Tubulointerstitial nephritis antigen-like 1 is a novel matricellular protein that promotes gastric bacterial colonization and gastritis in the setting of Helicobacter pylori infection.
Teng Y, Xie R, Xu J, Wang P, Chen W, Shan Z, Yan Z, Mao F, Cheng P, Peng L, Zhang J, Tian W, Yang S, Zhao Y, Chen W, Zou Q, Zhuang Y. Teng Y, et al. Cell Mol Immunol. 2023 Aug;20(8):924-940. doi: 10.1038/s41423-023-01055-4. Epub 2023 Jun 19. Cell Mol Immunol. 2023. PMID: 37336990 Free PMC article. - A Novel Design of Multi-epitope Vaccine Against Helicobacter pylori by Immunoinformatics Approach.
Ma J, Qiu J, Wang S, Ji Q, Xu D, Wang H, Wu Z, Liu Q. Ma J, et al. Int J Pept Res Ther. 2021;27(2):1027-1042. doi: 10.1007/s10989-020-10148-x. Epub 2021 Jan 2. Int J Pept Res Ther. 2021. PMID: 33424523 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- P30 DK058404/DK/NIDDK NIH HHS/United States
- R01 DK053620/DK/NIDDK NIH HHS/United States
- R21 DK063626/DK/NIDDK NIH HHS/United States
- R41 DK075161/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous